Summary
Endocyte Inc Endocyte is a biopharmaceutical company which develops targeted therapies for the treatment of cancer and inflammatory diseases. The company's pipeline products include EC1456, EC2629 used to treat solid tumors; EC1169, EC0652 targets prostate cancer; Vintafolide EC145 for cancer; EC2319 used to treat inflammatorydiseases; EC0371 for the treatment of polycystickidneydisease. Endocyte's proprietary small molecule drug conjugate SMDC technology is used to create novel SMDCs and companion imaging agents for personalized targeted therapies. The company is developing therapeutic immunotherapyapproachthatinvolvesthe retargetingofpotentimmunecells,calledchimeric antigen receptor Tcell CAR Tcell tofightcancer. It has operations in Indianapolis and West Lafayette, the US. Endocyte is headquartered in West Lafayette, Indiana, the US.
Endocyte Inc Key Recent Developments
Feb 27,2018: Endocyte Appoints Patrick Machado, J.D. to Its Board of Directors
Feb 26,2018: Endocyte Announces Phase 3 VISION Trial and Provides Update on Corporate Strategy and Reports Fourth Quarter and Year End 2017 Financial Results
Nov 06,2017: Endocyte Reports Third Quarter Financial Results
Sep 06,2017: Endocyte Presents Data at the 2017 CARTCR Summit Further Demonstrating the Ability to Manage Cytokine Release Syndrome Related to CAR TCell Therapy
Aug 16,2017: Endocyte Announces Presentations at the 254th American Chemical Society National Meeting Exposition
This comprehensive SWOT profile of Endocyte Inc provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Endocyte Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.
The profile contains critical company information including*,
Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Original Article: Endocyte Inc ECYT Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300
NEXT ARTICLE